• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

DugTown1's Profile

Avatar:

Membership:

Premium

Person Marks:

7

Total Posts:

52

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

1

Alias Born

03/07/2013 2:15:14 PM

Personal info

Recent Articles

• LendingClub Announces Q4 2024 Earnings Release and Call
• Columbia Lloyds Faces Credit Rating Downgrade by AM Best
• Dave Inc. Gears Up for Key Financial Conference Participation
• Crunch Fitness Provides Support During Wildfire Crisis
• Insurers Brace for Major Financial Impact from California Wildfires
• Albemarle Corporation Sets Date for Q4 2024 Earnings Report
• Danaher Partners with Innovaccer to Enhance Patient Care
• Aritzia Inc. Achieves Strong Q3 2025 Financial Performance
• Arthur J. Gallagher & Co. Prepares for Q4 2024 Earnings Report
• Nucor Enhances Operations with New Utility Structures Facility
• Newmark Group Unveils 2024 Financial Results and Insights
• Newmark Group to Release Q4 and Full Year 2024 Results Soon
• Dover's Upcoming Earnings Call: Key Details for Investors
• Brookdale Senior Living's Updated Occupancy Trends for December
• Cohen & Steers Reports December 2024 AUM and Net Inflows Update
• Federated Hermes Sets Date for Fourth Quarter Earnings Call
• SynCardia Systems Celebrates Patent for Next-Gen Heart Innovation
• Illumina Prepares for Q4 and Full Year 2024 Earnings Release
• eNavvi's Response to Crisis: Unlimited Prescription Support
• Tim Lamb Group Facilitates Strategic Acquisition of Daniels Dealerships
• Royalty Pharma's Latest Dividend Increase: What You Need to Know
• Wabash Celebrates Recognition as a Leading Responsible Company
• Understanding Voting Rights and Share Capital Basics
• Enact Holdings, Inc. Sets Earnings Call for Early February
• Intellia Therapeutics Focuses on Late-Stage Drug Advancements
• Mural Oncology's Pipeline Progress and 2025 Outlook
• Aptose Unveils Promising New Therapy for AML Patients
• Zefiro Methane Corp. Showcases Growth with New Corporate Insights
• Innovative Timing Solutions: Frequency Electronics at Needham
• Discover PagerDuty's Upcoming Presentation at Key Investment Event
• Diamondback Energy Announces Fourth Quarter Financial Call
• Viper Energy Plans Q4 2024 Results Call for Investors
• FORE Biotherapeutics Unveils Ambitious Pipeline Goals for 2025
• Highwoods Properties Set to Release Impressive Q4 2024 Results
• Kim Macaulay Joins Identiv as Senior Vice President of Sales
• ImmuCell Reports Impressive Sales Growth for Year-End Results
• Elevance Health Announces Conference Call for Q4 and Year-End Results
• Brookline Bancorp Reveals Earnings Call Details for Q4 2024
• JFrog Financial Results Announcement and Future Insights
• ResMed's Upcoming Earnings: What Investors Should Know
• FrontView REIT Provides Exciting Business Updates and Plans Ahead
• LPL Financial's Upcoming Earnings Release and Highlights
• Marea Therapeutics Reveals Exciting Milestones in Drug Development
• Phillips Edison & Company Expands Financing With Major Credit Facility
• QIAGEN Launches Innovative Gastrointestinal Testing Panel
• Dave Inc. to Showcase Innovations at Upcoming Conference
• Repare Therapeutics Shifts Focus to Key Cancer Treatments
• Gatos Silver Achieves Record Production Results for 2024
• Reinsurance Group of America Reveals Earnings Call Plans
• Transocean Ltd. Investors Can Join Major Class Action Lawsuit